CMA accuses 4 pharma companies of anti-competitive conduct

24-05-2019

CMA accuses 4 pharma companies of anti-competitive conduct

Piotr Swat / Shutterstock.com

Four pharmaceutical companies allegedly agreed not to compete for the supply of an anti-nausea tablet to the National Health Service (NHS), according to objections filed by the UK Competition and Markets Authority (CMA).


CMA, competition, antitrust, NHS, prochlorperazine, Competition and Markets Authority, collusion, drug suppliers

LSIPR